Autoimmune: All Phases trials

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome

Amifampridine Phosphate

Phase III

Lambert Eaton Myasthenic Syndrome

USA, France, Germany, Hungary, Poland, Russia, Serbia, Spain

Ongoing, not recruiting

Click here for further information


Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)

Bortezomib

Phase II

Myasthenia gravis

Germany

Recruiting

Click here for further information


A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations

IGIV-C

Phase III

Myasthenia gravis

Canada

Recruiting

Click here for further information


Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis

IGIV-C

Phase II

Myasthenia gravis

USA & Canada

Recruiting

Click here for further information


A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

IGIV-C

Phase II

Myasthenia gravis

USA

Recruiting

Click here for further information


Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

HIZENTRA®

Phase II

Myasthenia gravis

USA

Recruiting

Click here for further information


The Evaluation of Belimumab in Myasthenia Gravis

Belimumab

Phase II

Myasthenia gravis

USA, Canada, Germany & Italy

Ongoing, not recruiting

Click here for further information


Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Prednisone - Azathioprine

Phase III

Myasthenia gravis

France

Ongoing, not recruiting

Click here for further information


Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

CFZ533

Phase II

Myasthenia gravis

Denmark & Germany

Recruiting

Click here for further information


Efficacy of Methotrexate in Myasthenia Gravis

Methotrexate

Phase II

Myasthenia gravis

USA & Canada

Ongoing, not recruiting

Click here for further information


Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Eculizumab

Phase III

Multiple worldwide locations

Recruiting

Click here for further information


Phase II Trial of Rituximab In Myasthenia Gravis

Rituximab

Phase II

United States

Recruiting

Click here for further information


Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

NPB-01

Phase III

Japan

Recruiting

Click here for further information


Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome

GB-0998

Phase III

Japan

Recruiting

Click here for further information


Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 (EXTEND)

BIIB019 (Daclizumab High Yield Process)

Phase III

Multiple worldwide locations

Recruiting participants by invitation only.

Click here for further information


Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

DAC-HYP

Phase I

United States

Recruiting

Click here for further information


A Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis

Masitinib

Phase II

Spain

Recruiting

Click here for further information


Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Lisinopril

Phase II

United States

Recruiting

Click here for further information